ALA Diagnostics is a biotechnological start up that operates in the Healthcare Market and whose objectives are to become a developer and marketer of solutions for the diagnosis of pathologies with high prevalence and / or unmet medical needs.
ALA Diagnostics rises as a result of the identification of an opportunity for the development of a Multiple Sclerosis diagnostic kit, based on a patented recombinant protein and whose activity as a diagnostic biomarker has already been validated in 598 human samples.
It is the only clinically validated specific biomarker for the diagnosis of Multiple Sclerosis in blood. It is a rapid, simple, inexpensive, non-invasive diagnostic test, applicable to early diagnosis of the disease and easy to integrate into clinical routine.
ALA Diagnostics´ pipeline is based on products designed by clinical teams to solve the deficiencies that they find in the course of their care activity.
Company Details
- Employees
- 3
- Founded
- -
- Address
- Calle De López De Hoyos, 27, Madrid,community Of Madrid 28006,spain
- Industry
- Biotechnology Research
- NAICS
-
Research and Development in Biotechnology (except Nanobiotechnology)
- Website
- https://www.aladiagnostics.com
- Keywords
- Alcobendas.
- HQ
- Madrid, Community of Madrid
Ala Diagnostics, S.l. Questions
Ala Diagnostics, S.L.'s website is https://www.aladiagnostics.com
Ala Diagnostics, S.L.'s LinkedIn profile is https://es.linkedin.com/company/ala-diagnostics-s-l
Ala Diagnostics, S.L. has
3 employees.
View email and phone details for 3
employees at Ala Diagnostics, S.L..
Ala Diagnostics, S.L.'s industry is
Biotechnology Research
Ala Diagnostics, S.L.'s top competitors are
Columbiacare Services, Inc.,
Biohope,
Biohope Pharmaceutical,
Protein Alternatives Sl (Proalt),
Ala Diagnostics,
A4cell,
Spanish Drug Discovery Network (Sddn),
Sevibe Cells,
Durin Life Sciences Inc.,
Imagilys.
Ala Diagnostics, S.L.'s categories are Biotechnology Research
Ala Diagnostics, S.L.'s founding year is 2019
